CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, JD, MBA, Cerulean’s President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Deutsche Bank 40th Annual Health Care Conference in Boston on Thursday, May 7, 2015 at 9:20 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
